1000,000,000
Asian families’ health
企业愿景
Corporate Vision
–
成为亚洲益生菌行业标准制定者，以精准微生态干预技术守护
10亿亚洲家庭健康
–
To lead Asia’s probiotic industry by setting standards, protecting 800 million families through precision microbiome technology.
第一个五年发展蓝图
1st Five-Year Development Blueprint
战略路径
Strategic Roadmap
●科研驱动
– 构建”双高校（香港浸会大学+中山大学）—香港科学园—企业研发中心”铁三角体系
– 建立全球首个”AKK菌株+道地中药材”复合菌库，申请PCT国际专利保护
●Research-Driven
– Build an “Iron Triangle” system comprising “Dual Universities (Hong Kong Baptist University + Sun Yat-sen University) — Hong Kong Science Park — Corporate R&D Centers”
– Establish the world’s first “AKK Strains + Authentic Chinese Medicinal Herbs” composite strain library, with PCT international patent protection applications
●产品矩阵
推出三大产品线：
– 慢性病干预系列（肠炎/肥胖/高血糖）
– 免疫增强系列（季节型/术后康复型）
– 精准定制系列（基因检测+菌群适配）
●Product Matrix
Launch three major product lines:
– Chronic Disease Intervention Series (Enteritis/Obesity/Hyperglycemia)
– Immune Enhancement Series (Seasonal/Post-Surgical Recovery)
– Precision Customization Series (Genetic Testing + Microbiome Matching)
●市场渗透
– 实施”临床验证+社群教育+数字营销”三位一体推广模式
– 建立亚洲益生菌健康指数白皮书发布机制
● Market Penetration
– Implement a “Trinity Promotion Model” (Clinical Validation + Community Education + Digital Marketing)
– Establish an Asian Probiotic Health Index White Paper release mechanism
创新、研究与发展
Innovation, Research and Development
研发实力
●顶尖团队
汇聚中山大学、香港浸会大学等行业知名教授,团队发表超200篇行业顶级期刊论文(Cell、Neuron等),已有60+项多疗效应用发明专利。
●技术融合
国内顶级高校与香港名校联合实验室,推动中药现代化与益生菌技术的深度交叉创新。
Powerful R&D
●Top team
Bringing together renowned professors from Sun Yat Sen University and Hong Kong Baptist University, our team has published over 200 top tier journal articles (Cell, Neuron, etc.) and has obtained over 60 patents for multi therapeutic applications.
●Technology Integration
The joint laboratory of top domestic high schools and famous Hong Kong universities promotes the in-depth cross-innovation of Chinese medicine modernization and probiotic technology.
前沿技术突破
●功能原料复配(中药成分)+精准益生菌(功能性菌株研究)+下一代益生菌AKK
中药成分增强菌株活性,精准菌株解决靶向问题,AKK菌拓展健康边界,形成 “代谢-神经-肠道“全维度健康解决方案。
●天然化合物葛根素,打破了对于肠道吸收脂肪的传统认知
中药与益生菌协同创新:突破传统单一功效局限,结合葛根素、酸枣仁等中药活性成分,靶向调控“脑-肠轴”与代谢通路。
●自研多疗效应用发明专利植物乳植杆菌JF4
降低葡萄糖耐量,改善代谢和调节血糖,有效改善体重。
●下一代益生菌AKK菌
<脂肪代谢调控>AKK分泌蛋白P9显著抗糖、减重、脂肪肝。
<改善脑肠轴功能>通过提升短链脂肪酸水平,抑制小胶质细胞过度激活,缓解睡眠剥夺导致的认知障碍。
Technological Breakthrough
●Functional compound extraction (Chinese medicine ingredients)+precise probiotic (functional strain research)+Next generation probiotic AKK
Traditional Chinese medicine ingredients enhance the activity of bacterial strains, solve targeted problems with precise strains, AKK bacteria extended health frontier, and form a “metabolism-nerve-gut” multidimensional health solution.
●Natural compound puerarin rewrites the rule of nutrition absorption
Co-innovation of traditional Chinese medicine and probiotics:
Breaking through the limitations of traditional single efficacy, combining active ingredients of traditional Chinese medicine such as puerarin and jujube seeds, targeting the regulation of the “brain gut axis” and metabolic pathways.
●Self-Engineered Multi-Indication Therapeutic Patent: Lactobacillus plantarum JF4
Reduce glucose tolerance, improve metabolism & regulate blood sugar and effectively improve weight.
●Next generation probiotic AKK bacteria
<Regulation of Fat Metabolism>
AKK secretion protein P9 significantly inhibits glucose, weight loss, and fatty liver.
<Improving brain-gut axis function>
Achieving inhibite excessive activation of microglia, and alleviating cognitive impairment caused by sleep deprivation, by increasing the levels of short chain fatty acids.
迈泊生物科技 